Hollander David (CIK 1793796) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-06). Recent activity: Sell RVNC (9,733 shares), Sell RVNC (95,212 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | CMO & Global Therapeutics Lead | Sell | 9,733 | $35,525 |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | CMO & Global Therapeutics Lead | Sell | 95,212 | $0 |
Source: SEC Form 4 filings · as of 2025-02-06